The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States

2019 ◽  
Vol 18 (3) ◽  
pp. 209-217 ◽  
Author(s):  
Assaf Moore ◽  
Robert B. Den ◽  
Noa Gordon ◽  
Michal Sarfaty ◽  
Yulia Kundel ◽  
...  
2019 ◽  
Vol 37 (15_suppl) ◽  
pp. 6518-6518
Author(s):  
Assaf Moore ◽  
Robert Benjamin Den ◽  
Noa Gordon ◽  
Michal Sarfaty ◽  
Yulia Kundel ◽  
...  

6518 Background: Preoperative long-course chemoradiotherapy (CRT) and short-course radiotherapy (SCR) for locally advanced rectal cancer (LARC) were found to have equivalent outcomes in three randomized trials. SCR may have lower acute toxicity and the down-staging following CRT is more well-established. At present, SCR is frequently used in Europe but has not been widely adopted in the United States (US). It is standard to deliver radiotherapy by 3D planning, while the use of Intensity-modulated radiotherapy (IMRT) is controversial. In recent years there has been an increasing focus on understanding the cost and value of cancer care. In this study we aimed to assess the economic impact of fractionation scheme and treatment planning method for payers in the US. Methods: We performed a population-based analysis of the total cost of radiotherapy for LARC in the US annually. The national annual target population of patients was calculated using the Surveillance, Epidemiology, and End Results (SEER) database. Treatment costs for various fractionation schemes were based on billing codes and 2018 pricing by Medicare's Hospital Outpatient Prospective Payment System (OPPS). The cost of chemotherapy was based on the Payment Allowance Limits for Medicare Part B Drugs by Centers for Medicare and Medicaid Services (CMS). Results: We estimate that 12,945 patients with LARC are treated with radiotherapy annually in the US. The cost of CRT with 3-D or IMRT is US$ 15,881.76 and US$ 23,744.82 per patient, respectively. With 3-D SCR the cost is US$ 5,457 per patient. The use of SCR would lead to 64-77% annual savings of US$ 125,701,387 - US$ 236,727,934 in the US compared with 3-D and IMRT based CRT, respectively. IMRT based planning increases the total cost of CRT by 49% and if adopted widely would lead to an excess cost of US$ 101,787,312 annually. Conclusions: SCR may have the potential to save in the region of US$ 0.12-0.23 billion annually in the US, likely without impacting outcomes. Lack of evidence showing benefit with costly IMRT should limit its use to clinical trials. SCR may also lead to lower personal financial toxicity. It would be reasonable for public and private payers to consider which type of radiation is most suited to reimbursement.


Head & Neck ◽  
2020 ◽  
Vol 42 (8) ◽  
pp. 1713-1720 ◽  
Author(s):  
Assaf Moore ◽  
Robert B. Den ◽  
Aaron Popovtzer ◽  
Hadar Goldvaser ◽  
Noa Gordon ◽  
...  

Author(s):  
David D. B. Bates ◽  
Hiram Shaish ◽  
Marc J. Gollub ◽  
Mukesh Harisinghani ◽  
Chandana Lall ◽  
...  

2018 ◽  
Vol 61 (7) ◽  
pp. 753-754 ◽  
Author(s):  
Deborah S. Keller ◽  
Steven D. Wexner ◽  
Manish Chand

2019 ◽  
pp. 1-9
Author(s):  
Kelly Kisling ◽  
Lifei Zhang ◽  
Hannah Simonds ◽  
Nazia Fakie ◽  
Jinzhong Yang ◽  
...  

Purpose The purpose of this study was to validate a fully automatic treatment planning system for conventional radiotherapy of cervical cancer. This system was developed to mitigate staff shortages in low-resource clinics. Methods In collaboration with hospitals in South Africa and the United States, we have developed the Radiation Planning Assistant (RPA), which includes algorithms for automating every step of planning: delineating the body contour, detecting the marked isocenter, designing the treatment-beam apertures, and optimizing the beam weights to minimize dose heterogeneity. First, we validated the RPA retrospectively on 150 planning computed tomography (CT) scans. We then tested it remotely on 14 planning CT scans at two South African hospitals. Finally, automatically planned treatment beams were clinically deployed at our institution. Results The automatically and manually delineated body contours agreed well (median mean surface distance, 0.6 mm; range, 0.4 to 1.9 mm). The automatically and manually detected marked isocenters agreed well (mean difference, 1.1 mm; range, 0.1 to 2.9 mm). In validating the automatically designed beam apertures, two physicians, one from our institution and one from a South African partner institution, rated 91% and 88% of plans acceptable for treatment, respectively. The use of automatically optimized beam weights reduced the maximum dose significantly (median, −1.9%; P < .001). Of the 14 plans from South Africa, 100% were rated clinically acceptable. Automatically planned treatment beams have been used for 24 patients with cervical cancer by physicians at our institution, with edits as needed, and its use is ongoing. Conclusion We found that fully automatic treatment planning is effective for cervical cancer radiotherapy and may provide a reliable option for low-resource clinics. Prospective studies are ongoing in the United States and are planned with partner clinics.


Sign in / Sign up

Export Citation Format

Share Document